Recent advances in antioxidant capacity assays
If you use compounded products, ensure patients are informed that these drugs are not FDA-approved and that safety data may be limited
Regulatory Status in Canada BPC-157 is not approved by Health Canada for therapeutic use
Commonly reported GI side effects nausea, vomiting, diarrhea, constipation, abdominal pain, Site reactions, Fatigue & Headaches Who is not a candidate for GLP-1 at Revive Med Aesthetics
Women commonly explore BPC-157 for: Pregnant and breastfeeding women should avoid peptide therapy unless specifically advised by a qualified healthcare provider
It contains the active ingredient theacrine from Kucha Tea Extract, which provides energy without the jitters or crashes associated with caffeine